Financhill
Buy
59

ADUS Quote, Financials, Valuation and Earnings

Last price:
$125.05
Seasonality move :
6.85%
Day range:
$124.64 - $127.00
52-week range:
$85.94 - $136.12
Dividend yield:
0%
P/E ratio:
28.93x
P/S ratio:
1.88x
P/B ratio:
2.42x
Volume:
109.9K
Avg. volume:
147.9K
1-year change:
39.29%
Market cap:
$2.3B
Revenue:
$1.1B
EPS (TTM):
$4.37

Analysts' Opinion

  • Consensus Rating
    Addus HomeCare has received a consensus rating of Buy. The company's average rating is a Buy based on 8 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $137.82, Addus HomeCare has an estimated upside of 9.02% from its current price of $126.42.
  • Price Target Downside
    According to analysts, the lowest downside price target is $83.00 representing 34.35% downside risk from its current price of $126.42.

Fair Value

  • According to the consensus of 8 analysts, Addus HomeCare has 9.02% upside to fair value with a price target of $137.82 per share.

ADUS vs. S&P 500

  • Over the past 5 trading days, Addus HomeCare has overperformed the S&P 500 by 1.27% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Addus HomeCare does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Addus HomeCare has grown year-over-year revenues for 48 quarters straight. In the most recent quarter Addus HomeCare reported revenues of $289.8M.

Earnings Growth

  • Addus HomeCare has grown year-over-year earnings for 8 quarters straight. In the most recent quarter Addus HomeCare reported earnings per share of $1.10.
Enterprise value:
2.1B
EV / Invested capital:
--
Price / LTM sales:
1.88x
EV / EBIT:
19.33x
EV / Revenue:
1.83x
PEG ratio (5yr expected):
1.25x
EV / Free cash flow:
16.37x
Price / Operating cash flow:
16.87x
Enterprise value / EBITDA:
17.10x
Gross Profit (TTM):
$366M
Return On Assets:
6.89%
Net Income Margin (TTM):
6.5%
Return On Equity:
9.24%
Return On Invested Capital:
8.42%
Operating Margin:
8.96%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Income Statement
Revenue $928.7M $1B $1.1B $270.7M $289.8M
Gross Profit $293.8M $326.2M $366M $86.7M $92.2M
Operating Income $67.3M $83.8M $103.7M $22.8M $26M
EBITDA $82.2M $98.8M $121M $27M $31.3M
Diluted EPS $2.75 $3.55 $4.37 $0.95 $1.10
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Balance Sheet
Current Assets $299.4M $299.7M $240.1M $211.2M $332.8M
Total Assets $695.4M $924.9M $945.9M $1B $1.2B
Current Liabilities $93.7M $112.5M $128.2M $139.6M $157.8M
Total Liabilities $187.8M $366.9M $331.1M $351.4M $205.3M
Total Equity $507.6M $558.1M $614.8M $684.3M $947.6M
Total Debt $61.7M $220.7M $163.6M $163.9M --
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Cash Flow Statement
Cash Flow Operations $106M $106.5M $136.1M $21.8M $48.5M
Cash From Investing -$96.9M -$133.2M -$5.4M -$111.2M -$1.9M
Cash From Financing -$55.8M $786K $12.5M $85M $2.9M
Free Cash Flow $101.7M $96.9M $126.4M $19.4M $46.6M
ADUS
Sector
Market Cap
$2.3B
$47.1M
Price % of 52-Week High
92.87%
48%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
39.29%
-33.14%
Beta (5-Year)
1.002
0.754
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $125.82
200-day SMA
Buy
Level $119.62
Bollinger Bands (100)
Sell
Level 123.89 - 131.75
Chaikin Money Flow
Buy
Level 12.9M
20-day SMA
Sell
Level $126.86
Relative Strength Index (RSI14)
Buy
Level 51.07
ADX Line
Sell
Level 28.6
Williams %R
Neutral
Level -69.9772
50-day SMA
Buy
Level $125.17
MACD (12, 26)
Buy
Level 0.24
25-day Aroon Oscillator
Buy
Level 40
On Balance Volume
Neutral
Level 21.9M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (4.6545)
Buy
CA Score (Annual)
Level (1.2234)
Buy
Beneish M-Score (Annual)
Level (-2.714)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-1.3414)
Buy
Piotroski F Score (Annual)
Level (8)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (9)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are primarily medical in nature to those individuals who may require assistance during an illness or after surgery.

Stock Forecast FAQ

In the current month, ADUS has received 8 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ADUS average analyst price target in the past 3 months is $137.82.

  • Where Will Addus HomeCare Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Addus HomeCare share price will rise to $137.82 per share over the next 12 months.

  • What Do Analysts Say About Addus HomeCare?

    Analysts are divided on their view about Addus HomeCare share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Addus HomeCare is a Sell and believe this share price will drop from its current level to $83.00.

  • What Is Addus HomeCare's Price Target?

    The price target for Addus HomeCare over the next 1-year time period is forecast to be $137.82 according to 8 Wall Street analysts, 8 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is ADUS A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Addus HomeCare is a Buy. 8 of 8 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of ADUS?

    You can purchase shares of Addus HomeCare via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Addus HomeCare shares.

  • What Is The Addus HomeCare Share Price Today?

    Addus HomeCare was last trading at $125.05 per share. This represents the most recent stock quote for Addus HomeCare. Yesterday, Addus HomeCare closed at $126.42 per share.

  • How To Buy Addus HomeCare Stock Online?

    In order to purchase Addus HomeCare stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is ARK Next Generation Internet ETF a Good Investment?
Is ARK Next Generation Internet ETF a Good Investment?

The ARK Next Generation Internet ETF looks like a pretty…

Why Is Marvell Stock Up?
Why Is Marvell Stock Up?

Semiconductor and data infrastructure company Marvell Technology (NASDAQ:MRVL) absolutely trounced…

Why Is General Electric Stock Going Up?
Why Is General Electric Stock Going Up?

General Electric Company, doing business these days as GE Aerospace…

Stock Ideas

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Sell
44
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Sell
1
IONQ alert for Jan 10

IonQ [IONQ] is up 7.21% over the past day.

Sell
45
COLL alert for Jan 10

Collegium Pharmaceutical [COLL] is down 2.01% over the past day.

Sell
30
EDN alert for Jan 10

Empresa Distribuidora y Comercializadora Norte SA [EDN] is down 1.2% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock